Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded?

[1] Duker JS(2013)The international Vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole Ophthalmology 120 2611-2619

[2] Kaiser PK(2012)MIVI-TRUST study group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes N Engl J Med 367 606-615

[3] Binder S(2013)Symptomatic vitreomacular adhesion Retina 33 1503-1511

[4] de Smet MD(2011)The vitreomacular interface in retinal vein occlusion Acta Ophthalmol 89 e327-e331

[5] Gaudric A(2008)Vitreomacular traction and exudative age-related macular degeneration Acta Ophthalmol 86 470-481

[6] Reichel E(2011)Der Einfluss des Glaskörpers auf die Pathogenese der altersabhängigen Makuladegeneration Klin Monatsbl Augenheilkd 228 460-464

[7] Stalmans P(2015)Vitreomacular traction affects anti-vascular endothelial growth factor treatment outcomes for exudative age- related macular degeneration Retina 35 1750-1756

[8] Benz MS(2015)Influence of vitreomacular interface on anti- vascular endothelial growth factor therapy using treat and extend treatment protocol for age-related macular degeneration (VINTREX) Retina 35 1757-1764

[9] Gandorfer A(2001)Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature Graefes Arch Clin Exp Ophthalmol 239 325-333

[10] Kampik A(2008)Vitrectomy for diabetic macular oedema Eye (Lond) 22 1337-1341

[1] Duker JS(2013)The international Vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole Ophthalmology 120 2611-2619

[2] Kaiser PK(2012)MIVI-TRUST study group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes N Engl J Med 367 606-615

[3] Binder S(2013)Symptomatic vitreomacular adhesion Retina 33 1503-1511

[4] de Smet MD(2011)The vitreomacular interface in retinal vein occlusion Acta Ophthalmol 89 e327-e331

[5] Gaudric A(2008)Vitreomacular traction and exudative age-related macular degeneration Acta Ophthalmol 86 470-481

[6] Reichel E(2011)Der Einfluss des Glaskörpers auf die Pathogenese der altersabhängigen Makuladegeneration Klin Monatsbl Augenheilkd 228 460-464

[7] Stalmans P(2015)Vitreomacular traction affects anti-vascular endothelial growth factor treatment outcomes for exudative age- related macular degeneration Retina 35 1750-1756

[8] Benz MS(2015)Influence of vitreomacular interface on anti- vascular endothelial growth factor therapy using treat and extend treatment protocol for age-related macular degeneration (VINTREX) Retina 35 1757-1764

[9] Gandorfer A(2001)Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature Graefes Arch Clin Exp Ophthalmol 239 325-333

[10] Kampik A(2008)Vitrectomy for diabetic macular oedema Eye (Lond) 22 1337-1341